Thank You for Your Request!
Your press release submission has been received successfully.
Our editorial team will review the submitted details and get in touch with you shortly regarding publishing opportunities and the next steps.
For any assistance, please contact us at subscribe@ochre-media.com
Successfully repored......
Regards,
Client Success Team (CRM),
MENLO PARK, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, is scheduled to present a company overview at the 18th Annual Needham Healthcare Conference in New York at 3:30 p.m. ET on Tuesday, April 9, 2019. A live audio webcast of the presentation will be available on Geron’s website, www.geron.com/investors/events. If you are unable to listen to the live presentation, an archived webcast will be available on the Company’s website for 30 days. About Geron Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com. CONTACT: Suzanne Messere CG Capital
Investor and Media Relations
investor@geron.com
media@geron.com
877-889-1972
We take inappropriate content and abuse seriously. If you find this press release objectionable or believe it contains inappropriate content, please let us know.
